Strategy is feasible for advanced cancers; 157 regimens were administered to 210 patients, including 103 personalized combos ...

Prevalence, treatment utilization described for hypertension, diabetes mellitus, obesity, LDL-C, and cigarette smoking.

However, relief does not translate into measurable improvements in visual task performance or tear film metrics ...

Higher rates of glaucoma therapy seen at increasing IOP levels, with cutoff of 22 mm Hg influencing clinician decision-making ...

FDA grants Breakthrough Therapy designation to ianalumab for Sjögren disease after the monoclonal antibody showed significant disease improvement.

Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2025. The list includes several groundbreaking therapies that are expected to change the ...

HealthDay News — The rate of early termination or withdrawal in head and neck squamous cell carcinoma (HNSCC) clinical trials (CTs) has increased since 2000, with strategic decisions and poor ...

The FDA is expected to decide on treatments for allergic fungal rhinosinusitis, bipolar I disorder, Hunter syndrome, Leber hereditary optic neuropathy, ovarian cancer, and schizophrenia.

HealthDay News — Pharmacists and female pharmacy technicians have a higher risk for suicide than the general population, according to a study published January 8 in the American Journal of ...

Narcan Nasal Spray is an opioid antagonist that reverses the effects of opioids, including respiratory depression, sedation, and hypotension.

Manufacturers to remove suicidal ideation warnings from Saxenda, Wegovy, and Zepbound labels following a large-scale FDA safety investigation.

The US Centers for Disease Control and Prevention (CDC) is scaling back several childhood vaccine recommendations, prompting concerns that fewer kids will be pr ...